Iambic says new AI model bests AlphaFold as protein models rocket ahead
Announcements
This is some text inside of a div block.
February 14, 2024
Related announcements
Iambic to Present New Pre-Clinical NSCLC Data for IAM1363, a Selective Type II Inhibitor for HER2 Cancers, at the 2025 World Conference on Lung Cancer
